GGrantIndex
Sort

261,768 grants matching gene therapy

MOLECULAR CLASSIFICATION OF PROSTATE CANCER

$927,687
Sloan-Kettering Institute For Cancer Res · U01 · FY2002 · CA

Biological Functions of Chromosomal Proteins

$927,598
Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Chromosomal Proteins and Chromosomal Functions

$927,598
Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Genomic characterization and development of therapies for pediatric sarcoma

$927,446
John Shern · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Genomic dissection of tumor heterogeneity and progression

$927,446
John Shern · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Platform Technologies for Microscopic Retinal Imaging: Development & Translation

$927,431
Alfredo Dubra · Medical College Of Wisconsin · U01 · FY2015 · EY

Mutations of Chromatin and its Modifying Machineries in Malignancies

$927,430
Ali Shilatifard · Northwestern University At Chicago · R35 · FY2023 · CA

Investigating the heterogeneity and coordination of hematopoietic stem cells

$927,429
Rong Lu · University Of Southern California · R35 · FY2024 · HL

Generation of Hematopoietic Stem and Progenitor Cells from Human iPSCs

$927,414
Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

Small-molecule therapy for metastatic castration-resistant prostate cancer

$927,358
Daqing Wu · Metcure Therapeutics, Llc · R42 · FY2022 · CA

IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV Remission

$927,200
Vijayakumar Velu · Emory University · R56 · FY2024 · AI

Novel Extended Release Glaucoma Therapy for Once Daily Dosing

$927,111
Monica M Jablonski · University Of Tennessee Health Sci Ctr · R24 · FY2022 · EY

Vascular Growth and Regeneration

$927,076
Luisa Iruela-Arispe · University Of California Los Angeles · R35 · FY2019 · HL

Initiation of DNA replication in Mammalian Cells

$926,998
Mirit Aladjem · Basic Sciences · Z01 · FY2007 · CA

Preclinical Development of a Novel and Powerful Immunotherapeutic

$926,922
Susan Dana Jones · Immurx Llc · R44 · FY2011 · AI

National Cooperative Program for Infertility Research

$926,906
University Of Pennsylvania · U54 · FY2002 · HD

Advancing BITT-101 a novel dominant CD40 antagonist for use in treatment of Sjogren Syndrome.

$926,858
Kenneth Olivier · Boston Immune Technologies And Therapeutics, Inc. · R44 · FY2025 · AI

EMR Phenotypes and Community Engaged Genomic Associations

$926,828
Christopher G Chute · Mayo Clinic Rochester · U01 · FY2008 · HG

HIV Reservoir Ecology of Viral Remission (PTC)

$926,815
Jonathan Li · Brigham And Women'S Hospital · R01 · FY2025 · AI

Systems Biology of Angiogenesis in Peripheral Arterial Disease

$926,794
Aleksander S. Popel · Johns Hopkins University · R01 · FY2011 · HL

Sex-based Differences in Glioma

$926,753
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · P01 · FY2021 · CA

Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma

$926,748
Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Pediatric AIDS Clinical Trials Unit

$926,698
Ram Yogev · Lurie Children'S Hospital Of Chicago · U01 · FY2006 · AI

Mucosal Immune Defense Mechanisms of the Urinary Bladder

$926,653
Marco Colonna · Washington University · U01 · FY2016 · AI

CNS sirtuins in radiation-induced vascular permeability and neurodegeneration

$926,605
Deedee Smart · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA